Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation Source: Eur Respir J , 49 (4) 1601731; DOI: 10.1183/13993003.01731-2016 Year: 2017
Adipose tissue in obesity and obstructive sleep apnoea Source: Eur Respir J 2012; 39: 746-767 Year: 2012
Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007
Diabetes and metabolic aspects of OSA Source: Eur Respir Mon 2010; 50: 189-215 Year: 2010
Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea Source: Eur Respir J 2012; 39: 1136-1143 Year: 2012
Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: 156-160 Year: 2003
Cardiovascular and metabolic effects of CPAP in obese males with OSA Source: Eur Respir J 2007; 29: 720-727 Year: 2007
Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Significant associations between obstructive sleep apnea and fat accumulation in the liver in male subjects without visceral obesity Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Association between lipid peroxidation and inflammation in obstructive sleep apnoea Source: Eur Respir J 2006; 28: 378-385 Year: 2006
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation Source: Eur Respir J 2009; 33: 1195-1205 Year: 2009
The inflammation and insulin resistance in obstructive sleep apnea Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2003; 22: 251-257 Year: 2003
8-isoprostanes and resistin as markers of vascular damage in non-hypersomnolent obstructive sleep apnea patients Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Obstructive sleep apnoea and metabolic impairment in severe obesity Source: Eur Respir J 2011; 38: 1089-1097 Year: 2011
Relationship between obstructive sleep apnea syndrome (OSAS) and obesity, cholesterol disorders, blood pressure, and anatomical alterations Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006
Asthma, obesity, metabolic dysfunction and obstructive sleep apnoea Source: International Congress 2019 – State of the art session: Sleep and breathing disorders Year: 2019
Leptin, visfatin, insulin resistance, body composition change in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010
Carotid body inflammation and cardiorespiratory alterations in intermittent hypoxia Source: Eur Respir J 2012; 39: 1492-1500 Year: 2012